Tucson Medical
1 / 5
Indocyanine green (ICG) is a near-infrared fluorescent dye. When protein-bound, ICG can be excited by external light (wavelength range 750 ~ 810 nm) and emits near-infrared light at approximately 840nm. It has a blood half-life of 3 ~ 5 minutes. After entering the bloodstream and binding to proteins, it is absorbed by liver cells, enters the intestine via the biliary tract, and is eventually excreted.
This product represents a high-standard indocyanine green injection, having passed rigorous double consistency evaluations. With its high purity, low impurity content, and optimized storage conditions, it provides stable and reliable diagnostic options for the medical community.
Indications: Detection of choroidal neovascularization, macular lesions, intraocular tumors, and retinal vascular lesions. Also used for intraoperative staining of the capsule and internal limiting membrane.
Advantages: Provides clear choroidal vascular images for accurate diagnosis. In cataract and retinal surgeries, fluorescent staining helps identify structures accurately, reducing complications.
Indications: Evaluation of liver reserve function, liver tumor image development, liver segment identification, and bile leakage observation.
Advantages: ICG is an optimal method for evaluating liver reserve function due to its rapidity and safety, providing critical support for surgical decisions and improving structural identification.
Indications: Accurate localization of tumors, imaging of the lymphatic system, and assessment of blood supply.
Advantages: The fluorescence signal enhances target visibility, allowing for more intuitive judgment during operative procedures.
The product portfolio includes research, development, and production of high-end medical devices (fluorescence imaging series), fluorescence contrast agents (ICG, targeted series), and core components (fluorescence CMOS modules, endoscopes). These solutions are utilized in over 500 large hospitals.
Focusing on molecular fluorescence, Raman spectroscopy, AI, and computer-aided drug molecular design (CADD), the mission is to lead in molecular fluorescence technology through the synergy of medical devices and pharmaceuticals.
Recognized as a specialized "little giant" enterprise, the facility holds 131 core invention patents and 7 US invention patents. Strategic partnerships have been established with international leading companies in Germany and Japan, covering over 10 overseas countries.
